Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 40 years of age or older
- People whose breathlessness is rated at grade 2 or higher on a standard 0–4 breathlessness scale, meaning at least some limitation to daily activities due to shortness of breath
- People whose lung function tests show reduced airflow, specifically a post-inhaler FEV1 (a measure of how much air can be blown out in one second) below 70% of the expected value, and an FEV1/FVC ratio below 0.70 (confirm with trial site if unsure about your test results)
- People with a confirmed record of at least one moderate or severe COPD flare-up in the past year
- People whose answers to a standard sleep questionnaire suggest a possibility of obstructive sleep apnoea (a score above 3 on the STOP-Bang questionnaire)
- People who have access to a telephone or tablet, or who are willing to use one during the study
- People who are willing and able to follow all study procedures
- People who are covered by, or entitled to, medical care insurance
- People whose overnight sleep study shows 15 or more breathing pauses per hour and fewer than 5 central (brain-signal-related) apnoeas per hour of sleep
Who may not be able to join:
- People with severe daytime sleepiness, including a score above 14 out of 24 on the Epworth Sleepiness Scale, frequent sleepiness while driving, or a near-accident due to falling asleep at the wheel in the past 12 months
- People with serious, unstable heart or cardiovascular conditions, such as heart failure with reduced pumping function (FEVG 45% or below), recurring irregular heartbeat, unstable coronary artery disease, or recent stroke
- People currently using long-term oxygen therapy or a breathing support machine (non-invasive ventilation)
- People with a previously recorded high level of carbon dioxide in the blood (PaCO2 at or above 50 mmHg)
- People who have already been diagnosed with and are receiving treatment for obstructive sleep apnoea
- People who have a lung rehabilitation programme or lung volume reduction procedure planned within the coming year
- People who are pregnant or breastfeeding
- People who do not have a sufficient understanding of the French language
- People who fall under certain protected categories as defined by French public health law (confirm with trial site for details)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33680575272
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
annual rate of COPD exacerbations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.